Overview

A Study of LY3549492 in Healthy Weight Adult Participants

Status:
TERMINATED
Trial end date:
2025-08-14
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to evaluate the safety and tolerability of LY3549492 in adult participants with a healthy body max index (BMI) of 22 to 25 kilograms per square meter (kg/m2). Participation in the study will last about 13 months.
Phase:
PHASE2
Details
Lead Sponsor:
Eli Lilly and Company